Serum total tryptase levels are increased in patients with active chronic urticaria

Clinical and Experimental Allergy

Volumn 40, Issue 12, 2010, Pages 1760-1766

  Ferrer, M ^a   Nunez Cordoba J M ^b   Luquin, E ^a   Grattan, C E ^c   De La Borbolla, J M ^a   Sanz, M L ^a   Schwartz, L B ^d  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic urticaria; Mast cells; Tryptase

Indexed keywords

CD63 ANTIGEN; TRYPTASE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; CHRONIC URTICARIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL DEGRANULATION; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; AUTOIMMUNITY; BASOPHILS; CELL DEGRANULATION; CHRONIC DISEASE; HUMANS; MAST CELLS; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; TRYPTASES; URTICARIA; YOUNG ADULT;

EID: 78349276066     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03582.x     Document Type: Article

References (30)

1. Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981; 256:11939-43.
2. Jogie-Brahim S, Min HK, Fukuoka Y, Xia HZ, Schwartz LB. Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol 2004; 113:1086-92.
3. Schwartz LB, Bradford TR, Rouse C et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994; 14:190-204.
4. Bonadonna P, Perbellini O, Passalacqua G et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123:680-6.
5. Rueff F, Przybilla B, Bilo MB et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase - a study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity. J Allergy Clin Immunol 2009; 124:1047-54.
6. Trivedi NN, Raymond WW, Caughey GH. Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution. J Allergy Clin Immunol 2008; 121:1262-8.
7. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002; 346:175-9.
8. Gaig P, Olona M, Munoz LD et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004; 14:214-20.
9. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101:672-6.
10. Zuberbier T, Asero R, Bindslev-Jensen C et al. EAACI/GA(2)LEN/EDF/WAO guidelin: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-26.
11. Powell RJ, Du Toit GL, Siddique N et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007; 37:631-50.
12. Grattan CEH, Humphreys F. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157:1116-23.
13. Frezzolini A, Provini A, Teofoli P, Pomponi D, De Pita O. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006; 61:1071-7.
14. Szegedi A, Irinyi B, Gal M et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006; 155:67-75.
15. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression -inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105:552-60.
16. Yasnowsky KM, Dreskin SC, Efaw B et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006; 117:1430-4.
17. Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 2002; 129:254-60.
18. Schwartz LB, Min HK, Ren S et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol 2003; 170:5667-73.
19. Elias J, Boss E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986; 78:914-8.
20. Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983; 71:177-83.
21. Smith CH, Kepley C, Schwartz LB, Lee TH. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995; 96:360-4.
22. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109:694-700.
23. Grattan CE, Walpole D, Francis DM et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27:1417-24.
24. Hidvegi B, Nagy E, Szabo T et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria 1. Int Arch Allergy Immunol 2003; 132:177-82.
25. Kaplan AP, Horakova Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978; 61:350-4.
26. Hermes B, Prochazka AK, Haas N, Jurgovsky K, Sticherling M, Henz BM. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999; 103:307-14.
27. Deleuran B, Kristensen M, Larsen CG et al. Increased tryptase levels in suction-blister fluid from patients with urticaria. Br J Dermatol 1991; 125:14-7.
28. Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy 2010; 40:875-81.
29. Gyimesi E, Sipka S, Danko K et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151:388-96.
30. Kaplan A. Inflammation in chronic urticaria is not limited to the consequences of mast cell (or basophil) degranulation. Clin Exp Allergy 2010; 40:834-5.